Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study
Conclusion: Levofloxacin retained its therapeutic efficacy in patients assessed in a real-life setting, and high eradication rates were attained when it was administered as a single agent. A combination of an FQ with azithromycin induced a significant improvement of eradication rates. This strategy may be an interesting option in both first-referral and relapsing cases, although caution should be exercised when patients are at risk of developing arrhythmias, tendinitis, or other adverse effects.Chemotherapy
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research
More News: Arrhythmia | Azithromycin | Cancer & Oncology | Chemotherapy | Databases & Libraries | Levaquin | Statistics | Study | Urology & Nephrology | Zithromax